ArticleHuman genetics2016

Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.

Vinicius Tragante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.